Sugi Predict

Sugi Predict / Compounds / SCHEMBL1676266

SCHEMBL1676266

SCHEMBL1676266

O=C(O)CNC(=O)c1ccc(Cn2cc(-c3ccc(Cl)cc3Cl)nc2/C=C/c2ccc(-c3cccc(C(F)(F)F)c3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ S1PR5 Q9H228 1/20 0.38
▸ GCGR P47871 4/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ PPARG P37231 1/20 0.38
▸ NCOA2 Q15596 1/20 0.38
▸ NCOA1 Q15788 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ NCOA3 Q9Y6Q9 1/20 0.38
▸ EIF4E P06730 1/20 0.38
▸ EGLN1 Q9GZT9 3/20 0.37
▸ EGLN2 Q96KS0 1/20 0.37
▸ EGLN3 Q9H6Z9 1/20 0.37
▸ SHMT1 P34896 1/20 0.37
▸ SHMT2 P34897 1/20 0.37
▸ USP5 P45974 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1676269 1.00 HDAC1 (0.39) HDAC1HDAC6S1PR5GCGRMEN1
SCHEMBL1676613 0.93 HDAC1 (0.38) HDAC1HDAC6S1PR5MEN1KMT2A
SCHEMBL1676615 0.93 HDAC1 (0.38) HDAC1HDAC6S1PR5MEN1KMT2A
SCHEMBL5668692 0.91 S1PR5 (0.38) HDAC1HDAC6S1PR5GCGRMEN1
SCHEMBL1676181 0.91 CNR1 (0.40) S1PR5GCGRSHMT1SHMT2CNR1
SCHEMBL1676177 0.91 CNR1 (0.40) S1PR5GCGRSHMT1SHMT2CNR1
SCHEMBL1481124 0.91 MEN1 (0.42) HDAC1HDAC6S1PR5MEN1KMT2A
SCHEMBL1481125 0.91 MEN1 (0.42) HDAC1HDAC6S1PR5MEN1KMT2A
SCHEMBL1481397 0.89 S1PR5 (0.42) S1PR5GCGR
SCHEMBL1481399 0.89 S1PR5 (0.42) S1PR5GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110092553-A1 Substituted Azole Derivatives, Compositions, and Methods of Use TRANSTECH PHARMA, INC. (US) 2011-04-21 — — US disclosed
US-20110092553-A1 Substituted Azole Derivatives, Compositions, and Methods of Use TRANSTECH PHARMA, INC. (US) 2011-04-21 — — US disclosed
US-20110092553-A1 Substituted Azole Derivatives, Compositions, and Methods of Use TRANSTECH PHARMA, INC. (US) 2011-04-21 — — US disclosed
EP-1730118-A1 SUBSTITUTED AZOLE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Transtech Pharma, Inc. (US) 2006-12-13 — — EP disclosed
WO-2005080346-A1 SUBSTITUTED AZOLE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE TRANSTECH PHARMA, INC. (US) 2005-09-01 — — WO disclosed
US-20050187277-A1 Substituted azole derivatives, compositions, and methods of use TRANSTECH PHARMA, INC. 2005-08-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110092553-A1 Substituted Azole Derivatives, Compositions, and Methods of Use PTPRO, PTPN5, PTPRE HDAC1 1783/4885HDAC6 1818/4885S1PR5 3261/4885
US-20050187277-A1 Substituted azole derivatives, compositions, and methods of use PTPRO, PTPN5, PTPRE HDAC1 1783/4885HDAC6 1818/4885S1PR5 3261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.